UpDown | The leading social platform for virtual investing. Beat the market. Earn real money. Zero risk.

You need to upgrade your Flash Player

CATALYST PHARMA PARTNERS (CPRX) 0.70 $0.01 (1.45%) 11:50PM (15 mins delay)

CPRX

$0.70 $0.01 (1.45%)

You need to upgrade your Flash Player

Today

5d

1m

3m

1y

5y

10y

Last:	$0.70	High:	-
Prev Close:	$0.69	Low:	-
Open:	-	Mkt Cap:	$12M
Change:	$0.01 ( 1.45% )	52Wk High:	$2.84
Vol:	0	52Wk Low:	$0.39
Avg Volume:	59,954	Shares:	N/A
EPS:	-	PE Ratio:	-

Start trading CPRX with real money!

Company Description

A development-stage pharmaceutical company focused on the acquisition, development and commercialization of prescription drugs for the treatment of drug addiction.

	Louis Chung	Nov 20 9:56 AM
	Sold $2,148.60 of CPRX.

CATALYST PHARMA PARTNERS (CPRX) Stock News & Analysis

	Catalyst Receives Guidance from Nasdaq Regarding Minimum Bid Price Requirement	11/13/2009
	Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results	11/12/2009
	/C O R R E C T I O N -- Catalyst Pharmaceutical Partners, Inc./	11/12/2009
	U.S. Department of Defense Awards $1.2 Million to Study the Use of Vigabatrin to Reduce the Addictive Liability of Opiates While Still Effectively Managing Pain	11/10/2009
	Catalyst Pharmaceutical Partners, Inc. Announces Organizational Changes and Extension of Chief Executive's Employment Agreement	10/13/2009
	Catalyst Pharmaceutical Partners, Inc. Announces the Closing of $3.97 Million Registered Direct Offering	10/06/2009
	Catalyst Pharmaceutical Partners, Inc. Announces the Closing of $3.97 Million Registered Direct Offering	10/06/2009
	Catalyst Pharmaceutical Partners, Inc. To Raise $3.97 Million In Registered Direct Offering	10/01/2009
	Catalyst Pharmaceutical Partners, Inc. To Raise $3.97 Million In Registered Direct Offering	10/01/2009
	Catalyst Pharmaceutical Partners Continues Clinical Development of CPP-109 For The Treatment of Cocaine and Methamphetamine Addiction	09/30/2009
	Catalyst Pharmaceutical Partners To Transfer To NASDAQ Capital Market	09/02/2009
	Catalyst Pharmaceutical Partners Licenses Exclusive Rights to New Class of GABA Aminotransferase Inhibitors From Northwestern University	08/31/2009
	Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results	08/07/2009
	AllPennyStocks.com Announces July 27th to July 31st U.S. Penny Stocks 2 Watch (CPRX, HOKU)	07/24/2009	Baystreet.ca
	Catalyst Pharmaceutical Partners Announces Top-Line Results of CPP-109 Phase II Trial for Cocaine Addiction	05/29/2009

Write Your Own Stock Analysis

Do you have a hot tip on a stock? Share it with our community. Get started by entering the company name or symbol below.

© 2009 UpDown. All Rights Reserved.

Make a suggestion for this page

Data powered by QuoteMedia (Terms of Use). Data delayed 15 minutes unless otherwise indicated.